The post Do Federal Grants Sabotage Regulatory Reform? appeared on BitcoinEthereumNews.com. There’s been much attention to Donald Trump’s streamlining and “deconstruction” of conventional notice-and-comment regulation this year – a campaign that includes Congressional Review Act resolutions of disapproval overturning 16 late-term Biden regulations. Yet it’s notable that both houses of Congress have not come together on general regulatory process reform. Let the Deconstruction Commence Author and Competitive Enterprise Institute In the mid-1990s, state and local officials, concerns that their priorities were getting undermined by unfunded federal mandates, joined with small business to protest red tape. That rare, now almost unthinkable, bipartisan push produced several major reforms – signed into law by none other than Bill Clinton: Unfunded Mandates Reform Act (1995): Required disclosure of costs of certain federal mandates on businesses and state, local, and tribal governments; Paperwork Reduction Act Amendments (1995): Aimed to improve federal information management and curb paperwork-hour burdens on individuals, businesses and governments; Small Business Regulatory Enforcement Fairness Act (1996): Expanded small-business voice in rulemaking and created an ombudsman to help challenge overreach; Congressional Review Act (1996, part of SBREFA): Allowed Congress to review and nullify new federal regulations by joint resolution; Regulatory Right-to-Know Act (1998): Required an annual accounting of total regulatory costs and benefits by the Office of Management and Budget; Truth in Regulating Act (2000): A pilot program that authorized the Government Accountability Office to independently evaluate economically significant federal rules. While many of these contain loopholes or are simply disregarded, we now see the executive branch pursuing an unprecedented streamlining of conventional rulemaking. What’s missing is outside pressure – like that of the mid-1990s – to push Congress to make reforms such as Trump’s “one-in, ten-out” cost containment rule permanent. To be sure, bills have been introduced to do just that. Sen. Joni Ernst’s Searching for and Cutting Regulations that are Unnecessarily Burdensome… The post Do Federal Grants Sabotage Regulatory Reform? appeared on BitcoinEthereumNews.com. There’s been much attention to Donald Trump’s streamlining and “deconstruction” of conventional notice-and-comment regulation this year – a campaign that includes Congressional Review Act resolutions of disapproval overturning 16 late-term Biden regulations. Yet it’s notable that both houses of Congress have not come together on general regulatory process reform. Let the Deconstruction Commence Author and Competitive Enterprise Institute In the mid-1990s, state and local officials, concerns that their priorities were getting undermined by unfunded federal mandates, joined with small business to protest red tape. That rare, now almost unthinkable, bipartisan push produced several major reforms – signed into law by none other than Bill Clinton: Unfunded Mandates Reform Act (1995): Required disclosure of costs of certain federal mandates on businesses and state, local, and tribal governments; Paperwork Reduction Act Amendments (1995): Aimed to improve federal information management and curb paperwork-hour burdens on individuals, businesses and governments; Small Business Regulatory Enforcement Fairness Act (1996): Expanded small-business voice in rulemaking and created an ombudsman to help challenge overreach; Congressional Review Act (1996, part of SBREFA): Allowed Congress to review and nullify new federal regulations by joint resolution; Regulatory Right-to-Know Act (1998): Required an annual accounting of total regulatory costs and benefits by the Office of Management and Budget; Truth in Regulating Act (2000): A pilot program that authorized the Government Accountability Office to independently evaluate economically significant federal rules. While many of these contain loopholes or are simply disregarded, we now see the executive branch pursuing an unprecedented streamlining of conventional rulemaking. What’s missing is outside pressure – like that of the mid-1990s – to push Congress to make reforms such as Trump’s “one-in, ten-out” cost containment rule permanent. To be sure, bills have been introduced to do just that. Sen. Joni Ernst’s Searching for and Cutting Regulations that are Unnecessarily Burdensome…

Do Federal Grants Sabotage Regulatory Reform?

2025/10/22 02:51

There’s been much attention to Donald Trump’s streamlining and “deconstruction” of conventional notice-and-comment regulation this year – a campaign that includes Congressional Review Act resolutions of disapproval overturning 16 late-term Biden regulations. Yet it’s notable that both houses of Congress have not come together on general regulatory process reform.


Let the Deconstruction Commence

Author and Competitive Enterprise Institute

In the mid-1990s, state and local officials, concerns that their priorities were getting undermined by unfunded federal mandates, joined with small business to protest red tape. That rare, now almost unthinkable, bipartisan push produced several major reforms – signed into law by none other than Bill Clinton:

  • Unfunded Mandates Reform Act (1995): Required disclosure of costs of certain federal mandates on businesses and state, local, and tribal governments;
  • Paperwork Reduction Act Amendments (1995): Aimed to improve federal information management and curb paperwork-hour burdens on individuals, businesses and governments;
  • Small Business Regulatory Enforcement Fairness Act (1996): Expanded small-business voice in rulemaking and created an ombudsman to help challenge overreach;
  • Congressional Review Act (1996, part of SBREFA): Allowed Congress to review and nullify new federal regulations by joint resolution;
  • Regulatory Right-to-Know Act (1998): Required an annual accounting of total regulatory costs and benefits by the Office of Management and Budget;
  • Truth in Regulating Act (2000): A pilot program that authorized the Government Accountability Office to independently evaluate economically significant federal rules.

While many of these contain loopholes or are simply disregarded, we now see the executive branch pursuing an unprecedented streamlining of conventional rulemaking. What’s missing is outside pressure – like that of the mid-1990s – to push Congress to make reforms such as Trump’s “one-in, ten-out” cost containment rule permanent.

To be sure, bills have been introduced to do just that. Sen. Joni Ernst’s Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB ) Act would codify elements of the Trump and Department of Government Efficiency (DOGE) initiatives. The Guidance Out of Darkness (GOOD) Act would create permanent online portals for disclosure of sub-regulatory guidance documents, similar to portals established during Trump 1.0 that Biden revoked.

But there’s been little traction to move such bills to Trump’s desk. A stripped-down version of the REINS Act, which would have required congressional approval of certain regulations, was dropped from the “One Big Beautiful Bill” on procedural grounds; but so was more funding for the Office of Management and Budget to perform regulatory review.

What explains this lack of engagement or urgency?

Dampening Opposition

Back during the Biden administration, we noted that ballooning federal spending and regulation seemed to be swapping unfunded mandates for funded ones – transforming small business and what should be independent state and local governments into dependents appealing for still more federal funding. Progressives may have discovered that dollars can dampen what was once a strong coalition for regulatory reform.

If the deregulatory elements of Trump’s agenda are to work and endure, policymakers need to confront the reality that federal spending may now be buying off the natural opposition to Washington’s interference. Small businesses – beneficiaries of record-level federal loan guarantees – and state and local governments alike are queuing for dollars.

We’re talking huge sums. The Congressional Research Service’s (CRS) 2025 report Federal Grants to State and Local Governments: Trends and Issues estimates that federal grants-in-aid to lower-level governments for fiscal year 2024 exceed $1.1 trillion, around 16% of the entire federal budget.

That’s money originating in the states with taxpayers, orbiting Washington, and then returning – laden with strings.

CRS notes that these grants account for over a third of state and local government revenues, covering health care, transportation, education, job training, social services, and environmental protection – all ripe for federal “regulatory” influence once the dollars flow.

More than half of medical and social assistance programs are now federally funded, a dependency on display in the current shutdown.

CRS says that “the 10 largest federal grants to state and local governments comprised 77.5% of total outlays for federal grants to state and local governments.” Here’s that breakdown.

Largest Individual Federal Grant Outlays to State and Local Governments, “Federal Grants to State and Local Governments: Trends and Issues,” CRS, June 2025, p. 7.

Congressional Research Service

To be sure, grants in aid to states have been around for a long, long time; but there are more overlapping programs and agendas now, and the federal government has never been so large. Many programs have been affected by huge spending bills of recent vintage including the CARES Act, the Inflation Reduction Act and the Infrastructure Investment and Jobs Act. Late in his term, Biden toured the nation touting infrastructure money pouring into the states from Washington, and ridiculing Republicans who’d objected to it, joined on stage by federal, state and local politicians praising the grants and union labor and hoping for more.

Should we expect local politicians elected in this environment be interested in cutting spending and regulation?

Federalism, Anyone?

Federal grants-in-aid to states and localities – like the parallel universes of business subsidies, the contracting/procurement behemoth, and university grants – arrive not as blank checks, but as regulatory instruments. They can be laden with conditions, reporting requirements and guidance that extend Washington’s reach into every sphere. But for politicians and public administrators steeped in this system, it’s effectively a permanent party.

This cultivated dependency has eroded the prospects for limited government. What were once unfunded mandates that inspired rebellion are now funded mandates that pacify – and even energize – support for Washington’s involvement. Rather than resist new dictates, states chase grants that paradoxically bind them tighter. No wonder so many are marching now, furious over potential cuts during the shutdown.

Rather than federalism there is a systemic loss of independence at state and local levels, with Washington involved in everything.

Breaking The Cycle Of Dependency

Congress faces a choice. A generation ago, unfunded mandates made states and small business allies in the fight for red-tape relief. There was common cause in pushing back. Now, the common cause has shifted to chasing federal dollars. Rules that once might have spurred revolt are instead celebrated at conferences of mayors and governors because they come wrapped in checks. The only revolt comes when the money stops flowing.

A better approach on concerns like transportation, education, health, job training and all the other grant-in-aid programs is to leave the dollars in the states in the first place, as former U.S. Senator and federal judge James L. Buckley argued in Saving Congress from Itself. This should be accompanied by rollbacks of university funding (as opposed to the “compacts” being offered to them by Trump) and bans on private aid to businesses and corporations that invite Washington’s regulatory strings.

Reinvigorating a lasting coalition for regulatory reform will take more than unilateral trimming by the executive branch – or even the broader congressional streamlining urged here. It means confronting and breaking the deeper cycle of dependency that binds lower governments and the private sector alike to Washington’s purse. That will only happen by dismantling the federal statutes, agencies and commissions and consulting class that administer it all from the comfortable suburbs encircling Washington, D.C..

Until then, no one need ever fret over states rising up, they’ll line up instead.

Source: https://www.forbes.com/sites/waynecrews/2025/10/21/1-trillion-and-counting-do-federal-grants-sabotage-regulatory-reform/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Share Insights

You May Also Like

New Viral Presale on XRPL: DeXRP Surpassed $6.4 Million

New Viral Presale on XRPL: DeXRP Surpassed $6.4 Million

The post New Viral Presale on XRPL: DeXRP Surpassed $6.4 Million  appeared on BitcoinEthereumNews.com. One of the most talked-about ecosystems in the cryptocurrency space is the XRP Ledger (XRPL), and DeXRP, the first Presale on XRPL, recently made headlines for its growth story. Attracting over 9,300 investors globally, the project has now raised over $6.4 million and is rapidly emerging as one of the most viral cryptocurrency launches of 2025. By integrating AMM and Order Book trading with a cutting-edge LP system and an open voting process for holders, DeXRP hopes to establish itself as the preferred trading destination for the XRPL community. What is DeXRP?  As the first decentralized exchange (DEX) based on XRPL, DeXRP is taking center stage as XRP continues to solidify its place in the global market. Massive expectation has been generated by the combination of DeXRP’s ambition for an advanced trading platform and XRPL’s established infrastructure, which is renowned for its quick transactions, cheap fees, and institutional-ready capabilities. In contrast to a lot of speculative presales, DeXRP’s development shows both institutional interest and community-driven momentum. Its early achievement of the $6.4 million milestone demonstrates how rapidly investors are realizing its potential. DeXRP Presale Success More than 9,300 distinct wallets have already joined the DeXRP presale, indicating a high level of interest from around the world. A crucial aspect is highlighted by the volume and variety of participation: DeXRP is not merely a niche project; rather, it is emerging as a major force in the XRPL ecosystem. DeXRP’s recent collaborations with WOW Earn and Micro3, as well as its sponsorship of the WOW Summit in Hong Kong, are also contributing factors to this uptick in investor confidence. These actions are blatant attempts to increase the company’s awareness among institutional players and crypto-native groups. The Forbes article summed it up: DeXRP is embedding credibility where others chase hype, marking it as…
Share
2025/09/18 20:14
Share
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
2025/09/18 05:26
Share